We’re delighted to welcome Amy Coulson to CLCC in advance of starting her Ph.D. journey at Queen Mary University of London. Over the next 4 years she’ll be working with our team and QMUL’s Centre for Doctoral Training in Next Generation Organ on a Chip Technology (COaCT) to develop a vaginal organ-on-a-chip to grasp successful delivery of vaginal live biotherapeutics for bacterial vaginosis, using our hashtag#callavid drug delivery device. Amy brings her passion and experience for the space from a first-class MSc in Microbiome in Health & Disease from King’s College London, where she was involved in researching the complex relationships between the bridging bacteria of Fusobacterium nucleatum (polybacterial communities) and oral squamous cancer cell death.